Suffolk-based PBD Biotech has obtained funding from New Anglia Capital to support its international growth.

The start-up was founded about a year ago to develop and commercialise the Actiphage test from a technology originally used to detect tuberculosis in humans and adapted by Drs Cath Rees and Ben Swift at the University of Nottingham. Read more